 |
Technical Support
(877) SEPAX-US, press 3  TechSupport@sepax-tech.com |
  |
Search Results
Application
| Literature Reference: Novel Thienoduocarmycin-trastuzumab ADC Demonstrates Strong Anti-tumor Efficacy - View application note |
| MAb/ADC Fragment Separation after IDeS Digestion - View application note |
| Intact MAb, ADC and their Fragments Analysis on RP LC/MS - View application note |
| MAb Loading from Analytical to Prep HIC - View application note |
| MAb hydrophobicity screening on Proteomix HIC Butyl-NP5 - View application note |
| Erbitux and Rituximab Monoclonal Antibody Separation on Proteomix HIC Butyl NP5 - View application note |
| HICP1001 - Fusion protein Analysis on Proteomix® HICBu-NP5 ( 4603 ) - View application note |
| Analytical Characterization of Monoclonal Antibody IgG2 - View application note |
| Analytical Characterization of NIST MAb by Hydrophobic Interaction Chromatography (HIC) - View application note |
| Analytical Characterization of NIST MAb by Sepax SEC, HIC, RP and CEX - View application note |
| Literature Reference: Design and Characterization of Homogenous Antibody-drug Conjugates with a Drug-to-Antibody Ratio of One Prepared Using an Engineered Antibody and a Dual-maleimide Pyrrolobenzodiazepine Dimer - View application note |
| Literature Reference: Homogeneous Antibody-Drug Conjugates: DAR 2 Anti-HER2 Obtained by Conjugation on Isolated Light Chain Followed by mAb Assembly - View application note |
| Literature Reference: In-Depth Characterization for Methionine Oxidization in Complementary Domain Region by Hydrophobic Interaction Chromatography - View application note |
| Literature Reference: Structure-function Relationship Study for Sulfated Protein Therapeutics Using Hydrophobic Interaction Chromatography and Mass Spectrometry - View application note |